A comparison of tumour characteristics of screen-detected and interval cancers and their relationship with breast density and AJCC prognostic stage in a UK screening cohort - Top-Institutions - MDSpire

A comparison of tumour characteristics of screen-detected and interval cancers and their relationship with breast density and AJCC prognostic stage in a UK screening cohort

  • By

  • Fleur Kilburn-Toppin

  • Joshua Rothwell

  • Nicholas R. Payne

  • Yuan Huang

  • Sarah E. Hickman

  • Fiona J. Gilbert

  • May 6, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    BreastScreen Norway
    BreastScreen Norway

    Oslo, Norway

    Key Differentiators

    • Breast Cancer Screening

  • #2

    Cambridge University Hospitals NHS Foundation Trust
    Cambridge University Hospitals NHS Foundation Trust

    Cambridge, UK

    Key Differentiators

    • Oncology
    • Breast Cancer

  • #3

    Cambridge and Huntingdon, Norfolk and Norwich NHS Breast Screening programmes
    Cambridge and Huntingdon, Norfolk and Norwich NHS Breast Screening programmes

    Cambridge, UK

    Key Differentiators

    • Breast Cancer Screening

  • #4

    National Health Service Breast Screening Programme
    National Health Service Breast Screening Programme

    London, UK

    Key Differentiators

    • Breast Cancer Screening

  • #5

    Lund University
    Lund University

    Lund, Sweden

    Key Differentiators

    • Oncology
    • Medical Research

Original Source(s)

A comparison of tumour characteristics of screen-detected and interval cancers and their relationship with breast density and AJCC prognostic stage in a UK screening cohort

  • by Fleur Kilburn-Toppin, Joshua Rothwell, Nicholas R. Payne, Yuan Huang, Sarah E. Hickman, Fiona J. Gilbert

  • May 6, 2026

Related Content

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

Potential targets for boron transport in boron neutron capture therapy

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer